Floatz logo

LEUPROLIDE

Infertility

Ferring Pharmaceuticalsprotein_peptidePhase 4 / ApprovedDormant
BB
67/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
52/ 100
Competitive Position
89/ 100

Competitive context

26 Active assets in the Infertility cohort.

Asset / SponsorPhaseRating
CLOMIPHENE CITRATE
Sana'a University
Phase 4A
Metformin
Peking University Third Hospital
Phase 4A
Letrozole
GABRIEL MONTEIRO PINHEIRO
Phase 4BBB
Hcg
Damascus University
Phase 4BBB
Cetrotide
Fayoum University
Phase 4BBB

View all 46 →

Same molecule, other indications

LEUPROLIDE is also rated in:

prostate carcinomaDormant
BBB
Indicative ·
74 / 100
View asset →
metastatic prostate carcinomaDormant
BBB
Indicative ·
72 / 100
View asset →
prostate neoplasmDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →